AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure?

Recruitingn/aAges 18 Years - anyAllCharles University, Czech Republic
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Modern intensive care enables patients to survive insults that in the past would have been supralethal. Nonetheless, increased number of survivors suffer from failed functional outcomes associated with prolonged muscle weakness and fatiguability. Whilst alterations of skeletal muscle biology that occur during critical illness slowly disappear over the period of months, muscle weakness remains. Recent pilot studies have shown that muscle weakness is associated with loss and alteration of satellite skeletal muscle cells, which are supposed to proliferate and repair damaged muscle tissue. The pathogenesis of this phenomenon has not been fully understood. In this grant project, we will study function and structure of satellite cells and their organelles (particularly mitochondria) using both classical bioenergetics and advanced microscopic techniques. Satellite cells will be isolated from bi

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Eligibility Criteria for group of Critically ill patients: Inclusion Criteria: * Critically ill patients receiving mechanical ventilation, to be enrolled within 72 hours of admission, who are likely to need 7 days or more of ICU stay * Sudden onset of disease, which can be determined in time (such as trauma, stroke, sudden cardiac arrest etc.) * Informed consent signed by patient or patient's representative Exclusion Criteria: * Unlikely to survive 6 months * Premorbid downslope functional trajectory or poor performance status (ECOG Gr. 3 or worse) or baseline functional status unknown * Bleeding disorder (INRโ‰ฅ1.5 or PLT\< that would preclude muscle biopsies) * Known mitochondrial disease * Endocrine crisis as a reason for admission * Pregnant women Eligibility Criteria for a control group: Elective hip surgery patients with a very good to excellent performance status, only limited to joint pain (ECOG 0)
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Charles University
Prague, Czechia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy